Streetbeat News

Products Services

COYA

Coya Therapeutics' Phase 2 trial of high-dose interleukin-2 for Alzheimer's did not meet exploratory endpoints, leading to a 31.4% drop in stock price. The low-dose regimen showed some promise, with plans to advance it.

Portfolio Pulse from Vandana Singh

October 29, 2024 | 6:36 pm

APVO

Aptevo Therapeutics shares rose following the announcement that the company, in collaboration with Alligator Bioscience, will present interim Phase 1 data on their ALG.APV-527 monotherapy for advanced solid tumors at the SITC 2024 conference.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 6:34 pm

LLY

Eli Lilly released promising Phase 3b study results for donanemab, showing a significant reduction in amyloid-related imaging abnormalities in Alzheimer's patients using a modified dosing regimen. This could enhance the drug's profile by lowering risks associated with its use.

Portfolio Pulse from Vandana Singh

October 29, 2024 | 6:34 pm

SHPH

Shuttle Pharmaceuticals shares rose as the company started dosing patients in a Phase 2 clinical trial for Ropidoxuridine, targeting Glioblastoma.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 6:30 pm

AMKBY

KYOCY

The article highlights the investment philosophy of Walter Schloss, a value investor who achieved remarkable returns by focusing on financially sound companies trading below book value. It also discusses the potential of Kyocera Corp. and A.P. Moller-Maersk A/S as undervalued investment opportunities.

Portfolio Pulse from Tim Melvin

October 29, 2024 | 6:25 pm

DJT

Trump Media & Technology Group Corp. (NASDAQ:DJT) shares surged over 21% following a controversial campaign rally at Madison Square Garden. The stock is heavily influenced by Trump's presidential campaign events rather than company fundamentals. Despite the recent gains, investment fund manager Matthew Tuttle predicts a potential decline post-election, regardless of the outcome.

Portfolio Pulse from Erica Kollmann

October 29, 2024 | 6:20 pm

PACB

PacBio shares rose following the announcement of its new SPRQ sequencing chemistry for Revio sequencing systems.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 6:16 pm

AMD

F

GLW

GOOGL

QQQ

SOFI

SPY

XLK

Tech stocks rose as investors anticipated earnings from major companies like Alphabet and AMD. The Nasdaq 100 gained 0.7%, while the S&P 500 remained stable. Gold hit record highs, and Bitcoin neared its all-time high. Treasury yields climbed amid fiscal concerns.

Portfolio Pulse from Piero Cingari

October 29, 2024 | 5:54 pm

MSFT

SONY

Call of Duty: Black Ops 6 leads UK game charts despite a 10% drop in physical sales, likely due to Xbox Game Pass. PS5 dominates physical sales, while Xbox lags. The game sees strong Steam engagement but mixed reviews. Microsoft's Game Pass strategy is tested as it ends the $1 trial.

Portfolio Pulse from Franca Quarneti

October 29, 2024 | 5:53 pm

CCL

Holland America Line has adjusted its 2026 Grand World Voyage route to avoid the Red Sea due to evolving regional situations. The new route includes stops in eight countries and a Panama Canal transit.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 5:53 pm